Gilead Sciences Inc. (GILD)
NASDAQ: GILD
· Real-Time Price · USD
110.22
0.24 (0.22%)
At close: Jun 16, 2025, 2:16 PM
0.22% (1D)
| Bid | 104.22 |
| Market Cap | 137.1B |
| Revenue (ttm) | 28.73B |
| Net Income (ttm) | 5.96B |
| EPS (ttm) | 7.74 |
| PE Ratio (ttm) | 14.24 |
| Forward PE | 13.12 |
| Analyst | Buy |
| Ask | 110.3 |
| Volume | 2,454,679 |
| Avg. Volume (20D) | 9,325,242 |
| Open | 110.17 |
| Previous Close | 109.98 |
| Day's Range | 108.80 - 111.47 |
| 52-Week Range | 62.69 - 119.96 |
| Beta | 0.31 |
About GILD
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol GILD
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for GILD stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
-3.01%
Shares of pharmaceutical stocks are trading lower....
Unlock content with
Pro Subscription
1 month ago
-2.81%
Gilead Sciences shares are trading lower after the company reported worse-than-expected Q1 sales results and cut its FY25 EPS guidance.
23 hours ago · seekingalpha.com
Gilead Sciences: Strong Buy On Pipeline Momentum And Cost DisciplineInitiate Gilead Sciences with Strong Buy/$181 PT, citing disciplined cost base, accelerating pipeline, and robust Q1-25 execution driving margin and EPS outperformance. HIV franchise resilience and up...
